EXACT Financial Statements From 2010 to 2026

Stocks . USA . 
Stock . EXACT Sciences
EXAS Stock  USD 101.78  0.15  0.15%   
EXACT Sciences' financial statements offer valuable quarterly and annual insights to potential investors, highlighting the company's current and historical financial position, overall management performance, and changes in financial standing over time. Key fundamentals influencing EXACT Sciences' valuation are provided below:
Gross Profit
2.1 B
Profit Margin
(0.32)
Market Capitalization
19.3 B
Enterprise Value Revenue
6.7501
Revenue
3.1 B
There are over one hundred nineteen available fundamental measures for EXACT Sciences, which can be analyzed over time and compared to other ratios. All traders should verify EXACT Sciences' latest fundamentals against the performance from 2010 to 2026 and make sure the trends continue to evolve in the right direction. Market Cap is likely to gain to about 402.9 M in 2026. Enterprise Value is likely to gain to about 370.1 M in 2026

EXACT Sciences Total Revenue

3.33 Billion

Check EXACT Sciences financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among EXACT Sciences' main balance sheet or income statement drivers, such as Interest Expense of 38.6 M, Other Operating Expenses of 4.6 B or Research Development of 520.7 M, as well as many indicators such as Price To Sales Ratio of 4.1, Dividend Yield of 0.0 or PTB Ratio of 4.58. EXACT financial statements analysis is a perfect complement when working with EXACT Sciences Valuation or Volatility modules.
  
Build AI portfolio with EXACT Stock
Check out the analysis of EXACT Sciences Correlation against competitors.
For more information on how to buy EXACT Stock please use our How to Invest in EXACT Sciences guide.

EXACT Sciences Balance Sheet

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Total Assets7.2 B6.8 B3 B
Slightly volatile
Total Stockholder Equity2.9 B2.8 B1.4 B
Slightly volatile
Cash725.6 M691 M312.1 M
Slightly volatile
Cash And Short Term Investments1.3 B1.2 B640.1 M
Slightly volatile
Common Stock Shares Outstanding222.4 M211.8 M124.8 M
Slightly volatile
Liabilities And Stockholders Equity7.2 B6.8 B3 B
Slightly volatile
Other Stockholder Equity8.3 B7.9 B3.3 B
Slightly volatile
Total Liabilities4.3 B4.1 B1.6 B
Slightly volatile
Total Current Assets1.9 B1.8 B861.5 M
Slightly volatile
Other Current Liabilities442 M421 M166 M
Slightly volatile
Total Current Liabilities884.1 M842 M298.8 M
Slightly volatile
Property Plant And Equipment Net978.8 M932.2 M397.9 M
Slightly volatile
Accounts Payable108.2 M103 M37.7 M
Slightly volatile
Non Current Assets Total5.3 B5 B2.2 B
Slightly volatile
Common Stock Total Equity2.1 M2 M1.3 M
Slightly volatile
Property Plant And Equipment Gross1.6 B1.5 B522.8 M
Slightly volatile
Common Stock2.2 M2.1 M1.3 M
Slightly volatile
Property Plant Equipment826.8 M787.5 M339.1 M
Slightly volatile
Other Liabilities416.7 M396.8 M141.3 M
Slightly volatile
Short Term Investments527.8 M502.7 M329.5 M
Slightly volatile
Non Current Liabilities Total3.4 B3.2 B1.3 B
Slightly volatile
Current Deferred Revenue4.8 M5.1 M63.9 M
Pretty Stable
Short and Long Term Debt Total3.3 B3.2 B1.2 B
Slightly volatile
Long Term Debt2.8 B2.7 B1 B
Slightly volatile
Long Term Debt Total2.6 B2.5 B1 B
Slightly volatile
Capital Surpluse7.6 B7.3 B3.3 B
Slightly volatile
Non Current Liabilities Other381 M362.8 M135.9 M
Slightly volatile
Short Term Debt333.9 M318 M81.9 M
Slightly volatile
Net Receivables300.6 M286.3 M109.9 M
Slightly volatile
Short and Long Term Debt300.9 M286.5 M73.3 M
Slightly volatile
Net Invested Capital4.2 B5.7 B2.6 B
Slightly volatile
Long Term Investments2.4 M2.7 M2.9 M
Slightly volatile
Net Working Capital887.1 M965.1 M661 M
Slightly volatile
Capital Stock1.8 M2.1 M1.5 M
Slightly volatile
Capital Lease Obligations191.9 M212.2 M152.3 M
Slightly volatile

EXACT Sciences Income Statement

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Other Operating Expenses4.6 B4.4 B1.5 B
Slightly volatile
Research Development520.7 M495.9 M214.7 M
Slightly volatile
Total Operating Expenses3.6 B3.4 B1.2 B
Slightly volatile
Depreciation And Amortization259.4 M247.1 M93.2 M
Slightly volatile
Selling General Administrative1.7 B1.6 B527.1 M
Slightly volatile
Total Revenue3.3 B3.2 B1.1 B
Slightly volatile
Selling And Marketing Expenses226.2 M284.6 M259.5 M
Slightly volatile
Interest Income29.5 M28.1 M13.7 M
Slightly volatile
Reconciled Depreciation144.6 M247.1 M91.3 M
Slightly volatile
Non Recurring13.7 M14.4 M141.3 M
Slightly volatile

EXACT Sciences Cash Flow Statement

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Begin Period Cash Flow736.2 M701.1 M283 M
Slightly volatile
Depreciation259.4 M247.1 M93.2 M
Slightly volatile
Capital Expenditures164.2 M156.4 M85.3 M
Slightly volatile
Total Cash From Financing Activities202.6 M266.7 M294.8 M
Pretty Stable
End Period Cash Flow732.5 M697.6 M313.3 M
Slightly volatile
Stock Based Compensation259.5 M247.1 M108.3 M
Slightly volatile
Change To Netincome131.1 M208.5 M125.7 M
Slightly volatile

Financial Ratios

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Price To Sales Ratio4.14.31302
Slightly volatile
PTB Ratio4.583.885.5935
Pretty Stable
Days Sales Outstanding67.5437.88112
Slightly volatile
Book Value Per Share12.3211.749.1719
Slightly volatile
Average Payables195.2 K350.5 K358.6 K
Very volatile
Stock Based Compensation To Revenue0.08510.08960.7521
Slightly volatile
Capex To Depreciation0.60.572.3311
Slightly volatile
PB Ratio4.583.885.5935
Pretty Stable
EV To Sales4.955.21234
Slightly volatile
Inventory Turnover3.324.663.4104
Slightly volatile
Days Of Inventory On Hand12281.12163
Slightly volatile
Sales General And Administrative To Revenue0.560.5916.7206
Slightly volatile
Research And Ddevelopement To Revenue0.170.1817.8431
Slightly volatile
Capex To Revenue0.05390.05673.7192
Slightly volatile
Cash Per Share3.095.074.5132
Slightly volatile
Intangibles To Total Assets0.540.510.2927
Slightly volatile
Current Ratio2.342.477.3701
Slightly volatile
Receivables Turnover7.199.977.1328
Slightly volatile
Shareholders Equity Per Share12.3211.749.1719
Slightly volatile
Debt To Equity1.081.030.4998
Slightly volatile
Capex Per Share0.70.660.5469
Slightly volatile
Revenue Per Share14.1513.486.0478
Slightly volatile
Interest Debt Per Share14.313.626.7546
Slightly volatile
Debt To Assets0.440.420.2267
Slightly volatile
Operating Cycle189119275
Slightly volatile
Price Book Value Ratio4.583.885.5935
Pretty Stable
Ebt Per Ebit1.081.141.0798
Very volatile
Company Equity Multiplier1.212.221.5789
Slightly volatile
Long Term Debt To Capitalization0.460.440.2392
Slightly volatile
Total Debt To Capitalization0.50.480.2644
Slightly volatile
Debt Equity Ratio1.081.030.4998
Slightly volatile
Quick Ratio2.12.217.1797
Slightly volatile
Net Income Per E B T0.660.890.9203
Slightly volatile
Cash Ratio0.90.942.032
Slightly volatile
Days Of Inventory Outstanding12281.12163
Slightly volatile
Days Of Sales Outstanding67.5437.88112
Slightly volatile
Free Cash Flow Operating Cash Flow Ratio0.30.321.2649
Pretty Stable
Price To Book Ratio4.583.885.5935
Pretty Stable
Fixed Asset Turnover1.73.061.8985
Slightly volatile
Debt Ratio0.440.420.2267
Slightly volatile
Price Sales Ratio4.14.31302
Slightly volatile
Asset Turnover0.440.420.2407
Slightly volatile
Price Fair Value4.583.885.5935
Pretty Stable

EXACT Sciences Valuation Data

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Market Cap402.9 M383.8 M398.3 M
Slightly volatile
Enterprise Value370.1 M352.5 M365.6 M
Slightly volatile

EXACT Fundamental Market Drivers

Forward Price Earnings185.1852
Cash And Short Term Investments1 B

EXACT Upcoming Events

20th of February 2024
Upcoming Quarterly Report
View
14th of May 2024
Next Financial Report
View
31st of December 2023
Next Fiscal Quarter End
View
20th of February 2024
Next Fiscal Year End
View
30th of September 2023
Last Quarter Report
View
31st of December 2022
Last Financial Announcement
View

About EXACT Sciences Financial Statements

EXACT Sciences shareholders use historical fundamental indicators, such as revenue or net income, to determine how well the company is positioned to perform in the future. Although EXACT Sciences investors may analyze each financial statement separately, they are all interrelated. The changes in EXACT Sciences' assets and liabilities, for example, are also reflected in the revenues and expenses on on EXACT Sciences' income statement. Understanding these patterns can help investors time the market effectively. Please read more on our fundamental analysis page.
Last ReportedProjected for Next Year
Current Deferred Revenue5.1 M4.8 M
Total Revenue3.2 B3.3 B
Cost Of Revenue966.2 M1 B
Stock Based Compensation To Revenue 0.09  0.09 
Sales General And Administrative To Revenue 0.59  0.56 
Research And Ddevelopement To Revenue 0.18  0.17 
Capex To Revenue 0.06  0.05 
Revenue Per Share 13.48  14.15 
Ebit Per Revenue(0.34)(0.36)

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.
Explore Investing Ideas  

Additional Tools for EXACT Stock Analysis

When running EXACT Sciences' price analysis, check to measure EXACT Sciences' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy EXACT Sciences is operating at the current time. Most of EXACT Sciences' value examination focuses on studying past and present price action to predict the probability of EXACT Sciences' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move EXACT Sciences' price. Additionally, you may evaluate how the addition of EXACT Sciences to your portfolios can decrease your overall portfolio volatility.
Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions
 
Feedback Blog
Made with optimal in San Francisco
2026 Macroaxis LLC
COMMON DESTINATIONS
MAIN CATEGORIES
COMPANY